Search
for
Sort by
Research 121–150 of 1000+
- Tebentafusp-tebn (Kimmtra®)
- Incidence of alopecia from endocrine therapies in cancer
- c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- Latest advances in oral hormonal male contraception: efficacy, mechanisms of action, and future perspectives
- Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study
- Men??s Health
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Anthracycline analogs The past, present, and future
- Androgens and alopecia
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Redefining hormone resistance in prostate cancer
- Combination Therapies and the Theoretical Limits of Evidence-Based Medicine
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Therapeutic applications and pharmacoeconomics of microneedle technology
- Male hormonal contraception: looking back and moving forward
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Recent updates on Wnt signaling modulators: a patent review (2014-2020)
- Non-hemorrhage-related adverse effects of rivaroxaban
- Alopecia - the search for novel agents continues
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Interventions for preventing the progression of autosomal dominant polycystic kidney disease
- Hair characteristics and androgenetic alopecia in Koreans
- Prostate cancer update: 2007
- The role of androgens in hormone replacement therapy